Health News - The New York Times: Astrazeneca Begins A New Global Study Of Faslodex® (Fulvestrant) 500 MG Injection In Patients With Hormone Receptor-Positive Advanced Breast Cance

31 Ekim 2012 Çarşamba

Astrazeneca Begins A New Global Study Of Faslodex® (Fulvestrant) 500 MG Injection In Patients With Hormone Receptor-Positive Advanced Breast Cance

Hiç yorum yok:

Yorum Gönder

Kaydol: Kayıt Yorumları (Atom)